يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"León-Díaz, María"', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Ninguno

    المصدر: Revista Cubana de Medicina Intensiva y Emergencias; Vol. 21, No. 1 (2022): enero-marzo ; 1810-2352

    وصف الملف: application/pdf

    العلاقة: http://www.revmie.sld.cu/index.php/mie/article/view/884/pdfTest; http://www.revmie.sld.cu/index.php/mie/article/downloadSuppFile/884/175Test; http://www.revmie.sld.cu/index.php/mie/article/downloadSuppFile/884/176Test; Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018;39(2):119-177. DOI:10.1093/eurheartj/ehx393.; Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(14):1289-1367. DOI:10.1093/eurheartj/ehaa575.; Aster R, Curtis B, Bougie D, Dunkley S, Greinacher A, Warkentin T, et al. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost. 2006 ;4(3):678-9. DOI:10.1111/j.1538-7836.2006.01829.x.; Yi Y-H, Yin W-J, Gu Z-C, Fang W-J, Li D-Y, Hu C, et al. A Simple Clinical Pre -procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention. Front Pharmacol. 2018;9:1456. DOI:10.3389/fphar.2018.01456.; Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, et al. Expert consensus document on the use of antiplatelet agents: The Task Force on the Use of Antiplatelet Agents in Patients With Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. European Heart Journal, 2004;25(2):166-81. DOI:10.1016/j.ehj.2003.10.013; Yurtdaş M, Yaylali YT, Aladağ N, Özdemir M, Atay MHJCrim. Acute serious thrombocytopenia associated with intracoronary tirofiban use for primary angioplasty. Case Rep Med. 2014;2014:190149. DOI:10.1155/2014/190149.; Kalra K, Franzese CJ, Gesheff MG, Lev EI, Pandya S, Bliden KP, et al. Pharmacology of antiplatelet agents. Curr Atheroscler Rep. 2013;15(12):371. DOOI: 10.1007/s11883-013-0371-3.; Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013;27(3):137-45. DOI:10.1016/j.tmrv.2013.05.005.; Knight DJ, Selwyn D, Girling K, Lakshmanan S, Saha B, Rittoo D, et al. HIT/HITT and alternative anticoagulation: current concepts. Br J Anaesth. 2003;91(3):445; author reply 445-6. PMID: 12925492.; Lilly LS, Braunwald E. Braunwald's heart disease: preventive cardiology; atherosclerotic cardiovascular disease: Elsevier Health Sciences; Philadelphia, 2012;43-64; Abdeladim S, Elharras M, Elouarradi A, Bensahi I, Oualim S, Merzouk F, et al. Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases. Pan Afr Med J. 2021;38:9. DOI:10.11604/pamj.2021.38.9.27215.; Meghrajani V, Sabharwal N, Namana V, Elsheshtawy M, Topi BJCrih. A Case of Hyperacute Severe Thrombocytopenia Occurring Less than 24 Hours after Intravenous Tirofiban Infusion. Case Rep Hematol. 2018;2018:4357981. DOI:10.1155/2018/4357981.; Rauova L, Poncz M, McKenzie SE, Reilly MP, Arepally G, Weisel JW, et al. Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood. 2005;105(1):131-8. DOI:10.1182/blood-2004-04-1544.; Badimon L, Vilahur GJRedcs. Mecanismos de acción de los diferentes agentes antiplaquetarios. Revista Española de Cardiología Suplementos,2013;13(2):8-15 DOI:10.1016/S1131-3587(13)70074-8.; Liu YY, Dong QT, Guo YL, Wu NQ, Li JJ. Tirofiban-Induced Severe Thrombocytopenia. Am J Ther. 2019;26(5):e659-e661. DOI 10.1097/MJT.0000000000000861.; Wang S, Sawalha K, Khan A. An Unusual Case of Drug-Induced Thrombocytopenia. J Investig Med High Impact Case Rep. 2020;8:2324709620947891. DOI 10.1177/2324709620947891.; Rawala MS, Ahmed AS, Posina K, Sundaram V. Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect. J Community Hosp Intern Med Perspect. 2020;10(2):171-173. DOI:10.1080/20009666.2020.1747783.; http://www.revmie.sld.cu/index.php/mie/article/view/884Test

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10

    المؤلفون: León Díaz, María Eugenia

    المساهمون: Ariza Vargas, Erika Carolina, Vargas Nieto, Margarita Lucy

    المصدر: Repositorio Institucional UPN
    Universidad Pedagógica Nacional
    instacron:Universidad Pedagógica Nacional

    وصف الملف: PDF; application/pdf